Opioids: Casualty’s next market-turning event?
As market-turning events such as Enron fade from collective memory, Russell Group’s managing director Suki Basi discusses the dark clouds on the horizon for the casualty (re)insurance market.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below